Works matching IS 25785745 AND DT 2022 AND VI 4 AND IP 10


Results: 13
    1
    2
    3

    Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Ascending Dose Study

    Published in:
    ACR Open Rheumatology, 2022, v. 4, n. 10, p. 903, doi. 10.1002/acr2.11487
    By:
    • Abuqayyas, Lubna;
    • Cheng, Laurence E.;
    • Teixeira dos Santos, Marcia;
    • Sullivan, Barbara A.;
    • Ruiz‐Santiago, Norma;
    • Wang, Hui;
    • Zhou, Yanchen;
    • Chindalore, Vishala;
    • Cohen, Stanley;
    • Kivitz, Alan J.;
    • Posch, Maximilian G.;
    • Parnes, Jane R.
    Publication type:
    Article
    4
    5
    6
    7

    Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.

    Published in:
    ACR Open Rheumatology, 2022, v. 4, n. 10, p. 872, doi. 10.1002/acr2.11481
    By:
    • Izadi, Zara;
    • Gianfrancesco, Milena A.;
    • Aguirre, Alfredo;
    • Strangfeld, Anja;
    • Mateus, Elsa F.;
    • Hyrich, Kimme L.;
    • Gossec, Laure;
    • Carmona, Loreto;
    • Lawson‐Tovey, Saskia;
    • Kearsley‐Fleet, Lianne;
    • Schaefer, Martin;
    • Seet, Andrea M.;
    • Schmajuk, Gabriela;
    • Jacobsohn, Lindsay;
    • Katz, Patricia;
    • Rush, Stephanie;
    • Al‐Emadi, Samar;
    • Sparks, Jeffrey A.;
    • Hsu, Tiffany Y‐T;
    • Patel, Naomi J.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Issue Information.

    Published in:
    ACR Open Rheumatology, 2022, v. 4, n. 10, p. 833, doi. 10.1002/acr2.11284
    Publication type:
    Article